Topical treatment for acute phase Peyronie’s disease utilizing a new gel, H-100: a randomized, prospective, placebo-controlled pilot study
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Text and Data Mining valid from 2015-12-24
Version of Record valid from 2015-12-24
12 April 2015
13 June 2015
15 July 2015
24 December 2015
The authors declare no conflict of interest.
Free to read:
This content has been made available to all.